Eli Lilly and Company's bioethics framework for human biomedical research.
Current ethics and good clinical practice guidelines address various aspects of pharmaceutical research and development, but do not comprehensively address the bioethical responsibilities of sponsors. To fill this void, in 2010 Eli Lilly and Company developed and implemented a Bioethics Framework for Human Biomedical Research to guide ethical decisions. (See our companion article that describes how the framework was developed and implemented and provides a critique of its usefulness and limitations.) This paper presents the actual framework that serves as a company resource for employee education and bioethics deliberations. The framework consists of four basic ethical principles and 13 essential elements for ethical human biomedical research and resides within the context of our company's mission, vision and values. For each component of the framework, we provide a high-level overview followed by a detailed description with cross-references to relevant well regarded guidance documents. The principles and guidance described should be familiar to those acquainted with research ethics. Therefore the novelty of the framework lies not in the foundational concepts presented as much as the attempt to specify and compile a sponsor's bioethical responsibilities to multiple stakeholders into one resource. When such a framework is employed, it can serve as a bioethical foundation to inform decisions and actions throughout clinical planning, trial design, study implementation and closeout, as well as to inform company positions on bioethical issues. The framework is, therefore, a useful tool for translating ethical aspirations into action - to help ensure pharmaceutical human biomedical research is conducted in a manner that aligns with consensus ethics principles, as well as a sponsor's core values.
a a Eli Lilly and Company , Indianapolis , IN , USA.
Luann E
LE
Van Campen
a a Eli Lilly and Company , Indianapolis , IN , USA.
Donald G
DG
Therasse
a a Eli Lilly and Company , Indianapolis , IN , USA.
Mitchell
M
Klopfenstein
b b Yale University , New Haven , CT , USA.
Robert J
RJ
Levine
D026688:Bioethical Issues; D001675:Bioethics; D035843:Biomedical Research / Q000941:ethics*; D006801:Humans
Bioethics; Biomedical; Ethics; Framework; Pharmaceutical; Research; Sponsor